ketorolac

(redirected from Sprix)
Also found in: Dictionary, Thesaurus.
Related to Sprix: Toradol

ketorolac

 [ke″to-ro´lak]
a nonsteroidal antiinflammatory drug available as the tromethamine salt; used systemically for short-term management of pain; also applied topically to the conjunctiva in the treatment of allergic conjunctivitis and of ocular inflammation following cataract surgery.

ketorolac

/ke·to·ro·lac/ (ke″to-ro´lak) a nonsteroidal antiinflammatory drug available as the tromethamine salt; used systemically for short-term management of pain; also applied topically to the conjunctiva in the treatment of allergic conjunctivitis and of ocular inflammation following cataract surgery.

ketorolac

A NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) drug. Brand names are Acular and Toradol.

antiinflammatory drug 

A drug which inhibits or suppresses most inflammatory responses of an allergic, bacterial, traumatic or anaphylactic origin, as well as being immunosuppressant. They include the corticosteroids (e.g. betamethasone, dexamethasone, fluorometholone, hydrocortisone acetate, loteprednol etabonate, prednisolone, rimexolone, triamcinolone). They are sometimes combined with an antibiotic drug (e.g. betamethasone combined with neomycin or sulfacetamide, dexamethasone combined with neomycin or polymyxin B). Corticosteroids have side effects, such as enhancing the activity of herpes simplex virus, fungal overgrowth, raising intraocular pressure or cataract formation.There are other antiinflammatory drugs that are non-steroidal (NSAID) and have little toxicity. They act mainly by blocking prostaglandin synthesis. These include diclofenac sodium, flurbiprofen sodium, indomethacin, ketorolac, nepafenac and oxyphenbutazone. See immunosuppressants; steroid.

ketorolac

propionic acid derivative, nonsteroidal anti-inflammatory used for postoperative pain control in dogs and topically in ophthalmic conditions.
References in periodicals archive ?
Sprix Nasal Spray is a nonsteroidal anti-inflammatory drug (NSAID) indicated in adults for short-term (up to 5 days) management of moderate to moderately severe pain that requires analgesia at the opioid level.
As part of the agreement, the 37-person Ascend sales team will feature the SPRIX Nasal Spray as the priority product to healthcare practitioners in women's health.
According to the company, SPRIX Nasal Spray is a nonsteroidal anti-inflammatory drug (NSAID) indicated in adults for short-term (up to five days) management of moderate to moderately severe pain that requires analgesia at the opioid level.
This is the second partnership Egalet has entered to expand the commercial access of SPRIX Nasal Spray.
SPRIX Nasal Spray is a non-steroidal anti-inflammatory drug (NSAID) indicated in adult patients for the short-term (up to five days) management of moderate to moderately severe pain that requires analgesia at the opioid level.
It will be Teva's responsibility register, market, distribute and sell SPRIX Nasal Spray in these territories.
The deal will see Egalet receiving an undisclosed upfront payment, sales-based milestones and sharing in the profits from net sales of SPRIX in these territories.
Pharmaceutical company Egalet Corporation (NasdaqGM:EGLT) reported on Tuesday the establishment of its specialty sales force to support the promotion of SPRIX (ketorolac tromethamine) Nasal Spray and OXAYDO (oxycodone HCI, USP) tablets for oral use only -CII.
The sales representatives will begin making office visits to educate healthcare providers on SPRIX following the completion of sales training.